US Patent Issued to Hudson Institute of Medical Research on July 7 for "Method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (KRT14) residing on cancer cells" (Australian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,985, issued on July 7, was assigned to Hudson Institute of Medical Research (Clayton, Australia).

"Method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (KRT14) residing on cancer cells" was invented by Andrew Nicholas Stephens (Knoxfield, Australia) and Maree Bilandzic (Endeavour Hills, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods, uses and compositions for the treatment or prophylaxis of cancer in a mammalian subject comprising administering to the subject an amount of an agent which targets an extracellular portion of KRT14 or its functional homolog or varian...